Early trial tests new diabetes pill combo in healthy people
NCT ID NCT07102719
Summary
This early-stage study aimed to see how a new combination pill for diabetes (HD-P023) compares to taking two separate diabetes drugs (teneligliptin and empagliflozin) together. It involved 40 healthy adult volunteers to measure how the drugs move through the body and check for safety. The goal was to gather basic information to help design future studies in people with diabetes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H Plus Yangji Hospital
Seoul, 08779, South Korea
Conditions
Explore the condition pages connected to this study.